Because their gene expression profiles were quite distinct from the SCP lines, this allowed us to address to what extent the efficacy of TGF-β antagonists was dependent on intrinsic properties of tumor cell clones derived from the same parental line. The gene discussed is TGFB1; the disease is neoplasm.